Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database (Q5977801): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q35629751, #quickstatements; #temporary_batch_1709550817224 |
Added link to MaRDI item. |
||
(One intermediate revision by one other user not shown) | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
links / mardi / name | links / mardi / name | ||
Latest revision as of 16:49, 25 April 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database |
scientific article |
Statements
72
0 references
6
0 references
905-908
0 references
9 November 2011
0 references